Archives

  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-05
  • 2022-04
  • 2021-03
  • 2020-08
  • 2020-07
  • 2018-07
  • br Corresponding author br Felix Preisser MD br

    2022-09-16


    20 Corresponding author:
    21 Felix Preisser, MD
    22 Department of Urology, University Hospital Frankfurt, Frankfurt, Germany
    24 email: [email protected]
    29 Running head: Comparison of open and robotic CRP
    ACCEPTED MANUSCRIPT
    32 Disclosure of potential conflicts of interest:
    33 The authors declare that they Ferrostatin-1 have no conflict of interest.
    35 Research involving Human Participants and/or Animals:
    38 Informed consent:
    41 Authors’ Contribution statement:
    42 F. Preisser: Protocol/project development, Data analysis, Manuscript writing/editing
    43 S. Nazzani: Data analysis, Manuscript writing/editing
    44 E. Mazzone: Manuscript writing/editing
    45 M. Marchioni: Data collection or management
    46 M. Bandini: Data analysis
    47 Z. Tian: Data collection or management
    48 A. Haese: Manuscript writing/editing
    49 F. Saad: Manuscript writing/editing
    50 K. C. Zorn: Data analysis, Manuscript writing/editing
    51 F. Montorsi: Manuscript writing/editing
    52 S. F. Shariat: Manuscript writing/editing
    53 M. Graefen: Manuscript writing/editing
    54 D. Tilki: Protocol/project development, Manuscript writing/editing
    55 P. I. Karakiewicz: Protocol/project development, Data analysis, Manuscript writing/editing
    ACCEPTED MANUSCRIPT
    57 Microabstract
    58 Cytoreductive radical prostatectomy (CRP) may offer a survival advantage, according to several
    59 retrospective analyses. Within the National Inpatient Sample database, we tested intraoperative and
    60 postoperative complications of robotically-assisted CRP relative to open CRP in metastatic prostate
    61 cancer patients. The intraoperative and postoperative complications associated with robotically-
    62 Ferrostatin-1 assisted CRP are lower than those of open CRP.
    ACCEPTED MANUSCRIPT
    63 Abstract
    64 Purpose: Cytoreductive radical prostatectomy (CRP) may offer a survival advantage, according to
    65 several retrospective analyses. However, no direct comparisons are available regarding the type of
    66 surgical approach open vs. robotic in the metastatic setting. To address intraoperative and
    67 postoperative complications of robotically-assisted CRP relative to open CRP in metastatic prostate
    68 cancer patients.
    69 Patients and Methods: Within the National Inpatient Sample database (2008-2013), we identified
    70 metastatic prostate cancer patients Neutral substitution underwent robotically-assisted vs. open CRP. Multivariable
    71 logistic regression (MLR), Poisson regression models (MPR) and linear regression models were
    75 (p=0.5). In MLR models, robotically-assisted CRP resulted in lower rates of overall (Odds Ratio
    80 recorded after adjustment for clustering.
    81 Conclusion: The intraoperative and postoperative complications associated with robotically-
    82 assisted CRP are lower than those of open CRP. Similarly, robotically-assisted CRP is associated
    83 with shorter stay. Conversely, an increase in total hospital charges is associated with robotically-
    84 assisted CRP. Nonetheless, robotically-assisted CRP complication profile validates its safety and
    85 feasibility.
    86 Key words: robotic-assisted; metastatic; National Inpatient Sample; complications; cytoreductive
    87 prostatectomy
    ACCEPTED MANUSCRIPT
    89 Introduction
    90 Cytoreductive radical prostatectomy (CRP) may result in a survival benefit relative to no
    91 local therapy in patients with metastatic prostate cancer (mPCa), according to several retrospective
    92 reports 1-8. Several previous investigators demonstrated lower perioperative complications, when
    93 radical prostatectomy is performed with robotic-assistance, in clinically localized prostate cancer